» Articles » PMID: 26911533

The Possible Role of Chromosome X Variability in Hypertensive Familiarity

Overview
Journal J Hum Hypertens
Date 2016 Feb 26
PMID 26911533
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Familiarity participates in the pathogenesis of hypertension, although only recently, whole genome studies have proposed regions of the human genome possibly involved in the transmission of the hypertensive phenotype. Although studies have mainly focused on autosome, hitherto the influence of sex on familial transmission of hypertension has not been considered. We analysed the database of the Campania Salute Network of Hypertension center of the Federico II University Hospital of Naples (Italy), using dichotomous variables for paternal and maternal familiarity and gender (male and female) of 12 504 hypertensive patients (6868 males and 5636 females) and 6352 controls (3484 males and 2868 females), totaling 18 856 subjects. In the hypertensive group, familiarity was present in 75% of cases with odds of 3.77 and in only 26% of the normotensives with odds of 0.94. The odds ratio (OR) indicated that familiarity increases the risk of developing hypertension by 2.91 (95% confidence interval (CI)=2.67-3.17, P<0.001) times. Additionally, maternal familiarity was 37% (OR=3.01, 95% CI=2.66-3.41, P<0.001), paternal familiarity was 21% (OR=2.31, 95% CI=2.01-2.68, P<0.001) and the double familiarity was 17% (OR=3.45, 95% CI=2.87-4.01, P<0.001), thus suggesting a plausible association between maternal familiarity and development of hypertension; this finding was observed both in male and in female patients, although the phenomenon was larger in males. Given the dominance of maternal transmission in males, by genome-wide analysis of the X chromosome, we found two regions that were differently distributed in male hypertensives with maternal hypertension. Our data highlight the importance of genetic variants in the X chromosome to the maternal transmission of the hypertensive phenotype.

Citing Articles

Revisiting sex as a biological variable in hypertension research.

Ryan M, Clemmer J, Mathew R, Faulkner J, Taylor E, Abais-Battad J J Clin Invest. 2024; 134(17).

PMID: 39225093 PMC: 11364402. DOI: 10.1172/JCI180078.


Achieving a Systolic Blood Pressure Below 130 mmHg Reduces the Incidence of Cardiovascular Events in Hypertensive Patients with Echocardiographic Left Ventricular Hypertrophy.

Lembo M, Trimarco V, Izzo R, Manzi M, Rozza F, Gallo P J Pharmacol Exp Ther. 2023; 390(1):4-10.

PMID: 38135511 PMC: 11192578. DOI: 10.1124/jpet.123.001952.


Long-Lasting Control of LDL Cholesterol Induces a 40% Reduction in the Incidence of Cardiovascular Events: New Insights from a 7-Year Study.

Trimarco V, Izzo R, Gallo P, Manzi M, Forzano I, Pacella D J Pharmacol Exp Ther. 2023; 388(3):742-747.

PMID: 37775305 PMC: 10877706. DOI: 10.1124/jpet.123.001878.


The therapeutic concordance approach reduces adverse drug reactions in patients with resistant hypertension.

Trimarco V, Manzi M, Izzo R, Mone P, Lembo M, Pacella D Front Cardiovasc Med. 2023; 10:1137706.

PMID: 37215551 PMC: 10196370. DOI: 10.3389/fcvm.2023.1137706.


Therapeutic concordance improves blood pressure control in patients with resistant hypertension.

Trimarco V, Izzo R, Mone P, Lembo M, Manzi M, Pacella D Pharmacol Res. 2022; 187:106557.

PMID: 36402254 PMC: 9943685. DOI: 10.1016/j.phrs.2022.106557.


References
1.
Franklin S, Khan S, Wong N, Larson M, Levy D . Is pulse pressure useful in predicting risk for coronary heart Disease? The Framingham heart study. Circulation. 1999; 100(4):354-60. DOI: 10.1161/01.cir.100.4.354. View

2.
Devlin B, Roeder K . Genomic control for association studies. Biometrics. 2001; 55(4):997-1004. DOI: 10.1111/j.0006-341x.1999.00997.x. View

3.
Ellis J, Wong Z, Stebbing M, Harrap S . Sex, genes and blood pressure. Clin Exp Pharmacol Physiol. 2002; 28(12):1053-5. DOI: 10.1046/j.1440-1681.2001.03579.x. View

4.
Price A, Patterson N, Plenge R, Weinblatt M, Shadick N, Reich D . Principal components analysis corrects for stratification in genome-wide association studies. Nat Genet. 2006; 38(8):904-9. DOI: 10.1038/ng1847. View

5.
Mancia G, Zanchetti A, Bohm M, Christiaens T, Cifkova R, De Backer G . 2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J. 2013; 34(28):2159-219. DOI: 10.1093/eurheartj/eht151. View